Partners Healthcare System in Boston has integrated CT contrast media guidelines into its electronic medical record to encourage physicians to comply with the safety standards and to cut costs for the hospitals in its network.
Partners Healthcare System in Boston has integrated CT contrast media guidelines into its electronic medical record to encourage physicians to comply with the safety standards and to cut costs for the hospitals in its network.
In 2003 Partners' radiology administrative director Kathryn McCullough and members of the Partners CT Contrast Media Team started to assess contrast media administration guidelines and screening procedures for patients at risk for contrast reactions at the system's six hospitals.
After discovering wide variations in policies and procedures, they developed a standard code for contrast media administration plus a patient questionnaire and adverse reaction form, all available through the EMR. The initiative has allowed them to identify patients with a history of prior contrast reactions. The group published its results in the Journal of the American College of Radiology (JACR 2009;6:562-566).
Can Deep Learning Radiomics with bpMRI Bolster Accuracy for Prostate Cancer Prognosis?
January 22nd 2025An emerging deep learning radiomics model based on biparametric MRI (bpMRI) offered a 14 to 17 percent higher AUC range than PI-RADS scoring for predicting the aggressiveness of prostate cancer, according to new research findings.
PET Agent Gets FDA Fast Track Designation for Cardiac AL and ATTR Amyloidosis
January 22nd 2025Previously approved for the detection of neuritic beta amyloid plaque, the PET agent (18F)florbetaben is currently being evaluated in a phase 3 multicenter trial for the diagnosis of cardiac amyloidosis.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.